{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T09:39:11Z","timestamp":1784885951940,"version":"3.55.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T00:00:00Z","timestamp":1723680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T00:00:00Z","timestamp":1723680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-024-12766-w","type":"journal-article","created":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T11:02:14Z","timestamp":1723719734000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mecapegfilgrastim for prophylaxis of febrile neutropenia in children and adolescents with rhabdomyosarcoma or Ewing sarcoma: a prospective, single-arm, pilot study"],"prefix":"10.1186","volume":"24","author":[{"given":"Wen","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xisi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,15]]},"reference":[{"issue":"2","key":"12766_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3322\/caac.21219","volume":"64","author":"E Ward","year":"2014","unstructured":"Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):83.","journal-title":"CA Cancer J Clin"},{"issue":"15","key":"12766_CR2","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1056\/NEJMc2102423","volume":"384","author":"JA Ludwig","year":"2021","unstructured":"Ludwig JA, Meyers PA, Dirksen U. Ewing\u2019s sarcoma. N Engl J Med. 2021;384(15):1476.","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"12766_CR3","doi-asserted-by":"publisher","first-page":"e28254","DOI":"10.1002\/pbc.28254","volume":"68","author":"RL Yechieli","year":"2021","unstructured":"Yechieli RL, Mandeville HC, Hiniker SM, Bernier-Chastagner V, McGovern S, Scarzello G, et al. Rhabdomyosarcoma. Pediatr Blood Cancer. 2021;68(Suppl 2):e28254.","journal-title":"Pediatr Blood Cancer."},{"issue":"Suppl 1","key":"12766_CR4","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1016\/j.jinf.2015.04.026","volume":"71","author":"CD Barton","year":"2015","unstructured":"Barton CD, Waugh LK, Nielsen MJ, Paulus S. Febrile neutropenia in children treated for malignancy. J Infect. 2015;71(Suppl 1):S27\u201335.","journal-title":"J Infect"},{"issue":"12","key":"12766_CR5","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1001\/jamaoncol.2017.1114","volume":"3","author":"K Patel","year":"2017","unstructured":"Patel K, West H. Febrile neutropenia. JAMA Oncol. 2017;3(12):1751.","journal-title":"JAMA Oncol"},{"issue":"2","key":"12766_CR6","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s10147-022-02282-x","volume":"28","author":"S Osone","year":"2023","unstructured":"Osone S, Shinoda K, Yamamoto N, Suzuki K, Yano M, Ishida Y, et al. Current methods of preventing infectious disease and managing febrile neutropenia in childhood cancer patients: a nationwide survey in Japan. Int J Clin Oncol. 2023;28(2):331\u201340.","journal-title":"Int J Clin Oncol"},{"issue":"8","key":"12766_CR7","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1080\/17512433.2022.2110066","volume":"15","author":"H Kim","year":"2022","unstructured":"Kim H, Mousa SA. Colony stimulating factors for prophylaxis of chemotherapy-induced neutropenia in children. Expert Rev Clin Pharmacol. 2022;15(8):977\u201386.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"suppl 5","key":"12766_CR8","doi-asserted-by":"publisher","first-page":"v111","DOI":"10.1093\/annonc\/mdw325","volume":"27","author":"J Klastersky","year":"2016","unstructured":"Klastersky J, de Naurois J, Rolston K, Rapoport B, Maschmeyer G, Aapro M, et al. Management of febrile neutropaenia: ESMO clinical practice guidelines. Ann Oncol. 2016;27(suppl 5):v111\u20138.","journal-title":"Ann Oncol"},{"issue":"2","key":"12766_CR9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.cllc.2015.12.002","volume":"17","author":"C Zhou","year":"2016","unstructured":"Zhou C, Huang Y, Wang D, An C, Zhou F, Li Y, et al. A randomized multicenter phase III study of single administration of mecapegfilgrastim (HHPG-19K), a pegfilgrastim biosimilar, for prophylaxis of chemotherapy-induced neutropenia in patients with advanced non-small-cell lung cancer (NSCLC). Clin Lung Cancer. 2016;17(2):119\u201327.","journal-title":"Clin Lung Cancer"},{"issue":"9","key":"12766_CR10","doi-asserted-by":"publisher","first-page":"196","DOI":"10.21037\/atm.2019.04.10","volume":"7","author":"T Wang","year":"2019","unstructured":"Wang T, Wu B, Hu X, Liu J, Zhang T, Li F, et al. A randomized multicenter phase II trial of mecapegfilgrastim single administration versus granulocyte colony-stimulating growth factor on treating chemotherapy-induced neutropenia in breast cancer patients. Ann Transl Med. 2019;7(9):196.","journal-title":"Ann Transl Med"},{"issue":"18","key":"12766_CR11","doi-asserted-by":"publisher","first-page":"482","DOI":"10.21037\/atm.2019.07.95","volume":"7","author":"F Xu","year":"2019","unstructured":"Xu F, Zhang Y, Miao Z, Zeng X, Wu B, Cai L, et al. Efficacy and safety of mecapegfilgrastim for prophylaxis of chemotherapy-induced neutropenia in patients with breast cancer: a randomized, multicenter, active-controlled phase III trial. Ann Transl Med. 2019;7(18):482.","journal-title":"Ann Transl Med"},{"issue":"18","key":"12766_CR12","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1200\/JCO.2016.71.7017","volume":"35","author":"T Lehrnbecher","year":"2017","unstructured":"Lehrnbecher T, Robinson P, Fisher B, Alexander S, Ammann RA, Beauchemin M, et al. Guideline for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients: 2017 update. J Clin Oncol. 2017;35(18):2082\u201394.","journal-title":"J Clin Oncol"},{"issue":"23","key":"12766_CR13","doi-asserted-by":"publisher","first-page":"7361","DOI":"10.1158\/1078-0432.CCR-09-0761","volume":"15","author":"E Fox","year":"2009","unstructured":"Fox E, Widemann BC, Hawkins DS, Jayaprakash N, Dagher R, Aikin AA, et al. Randomized trial and pharmacokinetic study of pegfilgrastim versus filgrastim after dose-intensive chemotherapy in young adults and children with sarcomas. Clin Cancer Res. 2009;15(23):7361\u20137.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"12766_CR14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00280-016-3216-2","volume":"79","author":"MB Belogurova","year":"2017","unstructured":"Belogurova MB, Kizyma ZP, Garami M, Cs\u00f3ka M, Lamson MJ, Buchner A, et al. A pharmacokinetic study of lipegfilgrastim in children with Ewing family of tumors or rhabdomyosarcoma. Cancer Chemother Pharmacol. 2017;79(1):155\u201364.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"3","key":"12766_CR15","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/CAD.0b013e328011a532","volume":"18","author":"N Andr\u00e9","year":"2007","unstructured":"Andr\u00e9 N, Kababri ME, Bertrand P, Rome A, Coze C, Gentet JC, et al. Safety and efficacy of pegfilgrastim in children with cancer receiving myelosuppressive chemotherapy. Anticancer Drugs. 2007;18(3):277\u201381.","journal-title":"Anticancer Drugs"},{"issue":"6","key":"12766_CR16","doi-asserted-by":"publisher","first-page":"391","DOI":"10.2165\/00148581-200709060-00006","volume":"9","author":"D Walterhouse","year":"2007","unstructured":"Walterhouse D, Watson A. Optimal management strategies for rhabdomyosarcoma in children. Paediatr Drugs. 2007;9(6):391\u2013400.","journal-title":"Paediatr Drugs"},{"issue":"12","key":"12766_CR17","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1200\/JCO.2001.19.12.3091","volume":"19","author":"WM Crist","year":"2001","unstructured":"Crist WM, Anderson JR, Meza JL, Fryer C, Raney RB, Ruymann FB, et al. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. J Clin Oncol. 2001;19(12):3091\u2013102.","journal-title":"J Clin Oncol"},{"issue":"31","key":"12766_CR18","doi-asserted-by":"publisher","first-page":"5182","DOI":"10.1200\/JCO.2009.22.3768","volume":"27","author":"CAS Arndt","year":"2009","unstructured":"Arndt CAS, Stoner JA, Hawkins DS, Rodeberg DA, Hayes-Jordan AA, Paidas CN, et al. Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children\u2019s oncology group study D9803. J Clin Oncol. 2009;27(31):5182\u20138.","journal-title":"J Clin Oncol"},{"issue":"8","key":"12766_CR19","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1200\/JCO.2009.24.8872","volume":"28","author":"SL Spunt","year":"2010","unstructured":"Spunt SL, Irving H, Frost J, Sender L, Guo M, Yang BB, et al. Phase II, randomized, open-label study of pegfilgrastim-supported VDC\/IE chemotherapy in pediatric sarcoma patients. J Clin Oncol. 2010;28(8):1329\u201336.","journal-title":"J Clin Oncol"},{"issue":"5","key":"12766_CR20","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2165\/11586040-000000000-00000","volume":"50","author":"B-B Yang","year":"2011","unstructured":"Yang B-B, Kido A. Pharmacokinetics and pharmacodynamics of pegfilgrastim. Clin Pharmacokinet. 2011;50(5):295\u2013306.","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"12766_CR21","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.critrevonc.2013.12.006","volume":"90","author":"GH Lyman","year":"2014","unstructured":"Lyman GH, Abella E, Pettengell R. Risk factors for febrile neutropenia among patients with cancer receiving chemotherapy: a systematic review. Crit Rev Oncol Hematol. 2014;90(3):190\u20139.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"17","key":"12766_CR22","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1111\/1759-7714.14544","volume":"13","author":"XS Sun","year":"2022","unstructured":"Sun XS, Wang Z, Ren SH, Zhang HL, Liu LJ, Du HB, et al. PEG-rhG-CSF for prophylaxis of neutropenia after chemotherapy in patients with non-small cell lung cancer: a multicenter, prospective, randomized study. Thorac Cancer. 2022;13(17):2429\u201335.","journal-title":"Thorac Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12766-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-12766-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12766-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T11:02:45Z","timestamp":1723719765000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-12766-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,15]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["12766"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-12766-w","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,15]]},"assertion":[{"value":"20 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"According to the ethical guidelines of the Helsinki Declaration, the experimental protocol was established and approved by the ethics committee of Beijing Children\u2019s Hospital (IEC-C-006-A03-V.05). If the patients were older than 8\u00a0years, written informed consent was signed by both the patients and their parents; if the patients were under 8\u00a0years, written informed consent was signed only by the patients\u2019 parents.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1013"}}